Granahan Investment Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,751
| Closed | -$838K | – | 178 |
|
|
2022
Q2 | $838K | Sell |
8,751
-72,351
| -89% | -$8.68M | 0.03% | 165 |
|
|
2022
Q1 | $12M | Sell |
81,102
-74,905
| -48% | -$10.5M | 0.3% | 83 |
|
|
2021
Q4 | $22.1M | Sell |
156,007
-5,803
| -4% | -$822K | 0.46% | 55 |
|
|
2021
Q3 | $21.2M | Sell |
161,810
-23,311
| -13% | -$3.05M | 0.4% | 58 |
|
|
2021
Q2 | $25.4M | Buy |
185,121
+10,727
| +6% | +$1.47M | 0.47% | 50 |
|
|
2021
Q1 | $22.8M | Sell |
174,394
-37,313
| -18% | -$4.49M | 0.48% | 47 |
|
|
2020
Q4 | $23.7M | Sell |
211,707
-43,938
| -17% | -$4.16M | 0.53% | 49 |
|
|
2020
Q3 | $20.1M | Buy |
255,645
+51,764
| +25% | +$4.22M | 0.68% | 42 |
|
|
2020
Q2 | $14.7M | Buy |
203,881
+13,377
| +7% | +$931K | 0.53% | 56 |
|
|
2020
Q1 | $10.9M | Sell |
190,504
-751
| -0.4% | -$69.3K | 0.59% | 45 |
|
|
2019
Q4 | $21.4M | Sell |
191,255
-10,346
| -5% | -$1.1M | 0.98% | 30 |
|
|
2019
Q3 | $19.4M | Buy |
201,601
+11,676
| +6% | +$1.1M | 1.07% | 23 |
|
|
2019
Q2 | $16.3M | Sell |
189,925
-15,640
| -8% | -$1.29M | 0.8% | 37 |
|
|
2019
Q1 | $17.1M | Sell |
205,565
-20,477
| -9% | -$1.49M | 0.92% | 34 |
|
|
2018
Q4 | $14.5M | Sell |
226,042
-54,699
| -19% | -$3.74M | 1.03% | 33 |
|
|
2018
Q3 | $22.2M | Buy |
280,741
+14,479
| +5% | +$1.12M | 1.21% | 22 |
|
|
2018
Q2 | $19.5M | Buy |
266,262
+69,339
| +35% | +$4.72M | 1.17% | 21 |
|
|
2018
Q1 | $12.5M | Buy |
196,923
+90,927
| +86% | +$5.43M | 0.9% | 30 |
|
|
2017
Q4 | $5.4M | Buy |
105,996
+2,820
| +3% | +$147K | 0.43% | 84 |
|
|
2017
Q3 | $5.41M | Buy |
103,176
+6,791
| +7% | +$341K | 0.45% | 80 |
|
|
2017
Q2 | $4.91M | Sell |
96,385
-44,894
| -32% | -$2.22M | 0.45% | 82 |
|
|
2017
Q1 | $6.27M | Sell |
141,279
-340,146
| -71% | -$14.6M | 0.63% | 54 |
|
|
2016
Q4 | $21.3M | Buy |
481,425
+33,360
| +7% | +$1.42M | 0.73% | 51 |
|
|
2016
Q3 | $17.9M | Sell |
448,065
-144,000
| -24% | -$6.11M | 0.59% | 67 |
|
|
2016
Q2 | $28.3M | Sell |
592,065
-3,350
| -0.6% | -$142K | 1.03% | 22 |
|
|
2016
Q1 | $25M | Sell |
595,415
-10,000
| -2% | -$392K | 0.91% | 33 |
|
|
2015
Q4 | $26.7M | Buy |
605,415
+113,281
| +23% | +$4.92M | 0.92% | 28 |
|
|
2015
Q3 | $23.5M | Buy |
492,134
+26,700
| +6% | +$1.47M | 0.73% | 45 |
|
|
2015
Q2 | $27.1M | Buy |
465,434
+175,270
| +60% | +$9.45M | 0.77% | 42 |
|
|
2015
Q1 | $14.7M | Buy |
+290,164
| New | +$14.2M | 0.42% | 87 |
|
Other funds holding CNMD
CIP
Granahan Investment Management's CNMD Position: Q3 2022 in Review
Granahan Investment Management sold out of CONMED (CNMD) in Q3 2022, closing a stake of 8,751 shares — an estimated $838K sold.
Granahan Investment Management first reported a position in CNMD in Q1 2015 and held it in 30 quarters. The position peaked at $28.3M in Q2 2016. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.
- Granahan Investment Management reported no remaining CONMED position as of Q3 2022 after selling out during the quarter.
- Granahan Investment Management sold 8,751 CONMED shares in Q3 2022, an estimated $838K.
- Granahan Investment Management first reported a position in CONMED in Q1 2015 and held it in 30 quarters.
- Granahan Investment Management's CONMED position peaked at $28.3M in Q2 2016.
- 252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.
Based on Granahan Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.